Nowal Al Baqui, MD
Nephrology · Fairfax, VANPI 1639432198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $205 and has fallen 55.2% since, to $92 in 2025. That places this record below the midpoint for nephrology clinicians in VA, where the typical reported total is $807.
Across 36 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$122
- Novo Nordisk$110
- Johnson & Johnson$97
- Paratek Pharmaceuticals, Inc.$79
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$69
- Portola Pharmaceuticals, LLC$33
- plus $280 from 13 others
What the payments were for
- Food & beverage$789100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$789 in reported general payments places this provider in the 45th percentile of 298 nephrology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $7,958 |
| Cefpodoxime Proxetil | 12 | $372 |
| Metoprolol Succinate | 16 | $133 |
| Pantoprazole Sodium | 16 | $117 |
| Cefdinir | 23 | $107 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $96 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $68 |
| Oxycodone Hcl | 19 | $66 |
| Doxycycline Hyclate | 13 | $66 |
| Hydralazine Hcl | 12 | $54 |
| Metoprolol Tartrate | 13 | $54 |
| Amlodipine Besylate | 15 | $49 |
| Cyclobenzaprine Hcl | 11 | $48 |
| Carvedilol | 13 | $35 |
| Prednisone | 24 | $31 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Fairfax
- Reza ZonoziFairfax$262K
- Renuka SothinathanFairfax$68K
- Ali AssefiFairfax$64K
- Kinjal PatelFairfax$31K
- Paul ModlingerFairfax$18K
- Magnus IkhinmwinFairfax$11K
- Renu Regunathan-ShenkFairfax$6K
- Ranjit CheriyanFairfax$4K
- Ramon MendezWoodbridge$791K
- Sandeep MagoonNorfolk$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.